Purushottam Chatterjee
Purushottam Chatterjee publishes mostly in Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Epidemiology, on topics such as Diabetes Treatment and Management, Diabetes Management and Research and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #5,571,090 of 7,710,434 ranked researchers
- Rank in India
- #164,344 of 280,097
- Works
- 16
- Citations
- 142
- Citations per work
- 8.9
What does Purushottam Chatterjee research?
Purushottam Chatterjee's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences953.2%
- Medicine953.2%
- Everything else742.4%
- Life Sciences14.4%
- 1Endocrinology, Diabetes and Metabolism33% of their works
- 2Pediatrics, Perinatology and Child Health7% of their works
- 3Epidemiology4% of their works
- 4Molecular Biology4% of their works
- 5Physiology4% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Vitamin D Research Studies
- Birth, Development, and Health
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
- Sexual Differentiation and Disorders
Which keywords describe Purushottam Chatterjee's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Cardiovascular Outcomes, Type 2 Diabetes, Diabetes, Metabolic Syndrome and Continuous Glucose Monitoring.
- Steroid 21-Hydroxylase Deficiency
- Congenital Adrenal Hyperplasia
- Obesity
- Hyperglycemia
- Early-Life Conditions
- Critical Care
- Continuous Glucose Monitoring
- Diabetes
- Cardiovascular Outcomes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Type 2 Diabetes
- Metabolic Syndrome
- Hypoglycemia
- Deficiency
- Fetal Programming
- Insulin Resistance
- Vitamin D
- Sex Determination
- X Chromosome Inactivation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Glycemic Control113 topics
- Insulin Therapy113 topics
- Cardiovascular Disease73 topics
- Cardiovascular Outcomes61 topic
- Type 2 Diabetes61 topic
- Diabetes52 topics
- Metabolic Syndrome42 topics
- Continuous Glucose Monitoring31 topic
- Hypoglycemia31 topic
- Critical Care21 topic
- Deficiency21 topic
- Early-Life Conditions21 topic
- Fetal Programming21 topic
- Hyperglycemia21 topic
- Insulin Resistance21 topic
- Obesity21 topic
- Vitamin D21 topic
- Congenital Adrenal Hyperplasia11 topic
- Sex Determination11 topic
- Steroid 21-Hydroxylase Deficiency11 topic
- X Chromosome Inactivation11 topic
Where does Purushottam Chatterjee work?
Purushottam Chatterjee's main affiliation in the publication record is Apollo Gleneagles Hospitals, India.
How many publications and citations does Purushottam Chatterjee have?
OpenAlex counts 16 works and 142 citations for Purushottam Chatterjee, an h-index of 7, ranking #5,571,090 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Purushottam Chatterjee. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.